---
title: Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power
nct_id: NCT06884566
overall_status: COMPLETED
phase: NA
sponsor: University of Central Lancashire Cyprus
study_type: INTERVENTIONAL
primary_condition: Taurine
countries: Cyprus
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06884566.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06884566"
ct_last_update_post_date: 2025-03-19
last_seen_at: "2026-05-12T07:08:31.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power

**NCT ID:** [NCT06884566](https://clinicaltrials.gov/study/NCT06884566)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 17
- **Lead Sponsor:** University of Central Lancashire Cyprus
- **Conditions:** Taurine
- **Start Date:** 2025-01-07
- **Completion Date:** 2025-01-21
- **CT.gov Last Update:** 2025-03-19

## Brief Summary

This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs.

## Detailed Description

The purpose of this study is to further investigate any potential ergogenic effects offered by taurine, under specific conditions, namely that of acute supplementation, as opposed to the chronic supplementation protocols of many popular ergogenic aids, such as creatine and beta alanine. Exercise modes investigated include maximal isometric strength, maximal instantaneous power generation, and sustained maximal anaerobic power output, investigated via grip strength, vertical jump height, and the Wingate test, respectively.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 40 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* participants 18 - 40 years of age
* physically active or recreationally active with consistent training more than 3 times per week for at least 6 months
* non-smokers

Exclusion Criteria:

* cardiovascular, respiratory or metabolic diseases
* any musculoskeletal injury in the last six months
* taking taurine and/or creatine supplementation in the past three months
```

## Arms

- **Taurine supplementation** (EXPERIMENTAL) — Participants consumed 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink.
- **Placebo** (PLACEBO_COMPARATOR) — Placebo was a 500ml sugar-free lemonade drink with nothing added

## Interventions

- **Taurine supplementation** (DIETARY_SUPPLEMENT) — For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.
- **Placebo** (DIETARY_SUPPLEMENT) — For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.

## Primary Outcomes

- **Maximal Isometric strength in kilograms assessed via handgrip test** _(time frame: Day 1)_
- **Relative Isometric strength in kilograms assessed via handgrip test** _(time frame: Day 1)_
- **Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.** _(time frame: Day 1)_
- **Average Instantaneous power generation in W/kg assessed via vertical jump height test.** _(time frame: Day 1)_
- **Peak power in Watts assessed via the Wingate Anaerobic test** _(time frame: Day 1)_
- **Maximal Isometric strength in kilograms assessed via handgrip test** _(time frame: After 48 hours)_
- **Relative Isometric strength in kilograms assessed via handgrip test** _(time frame: After 48 hours)_
- **Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.** _(time frame: After 48 hours)_
- **Average Instantaneous power generation in W/kg assessed via vertical jump height test.** _(time frame: After 48 hours)_
- **Peak power in Watts assessed via the Wingate Anaerobic test** _(time frame: After 48 hours)_

## Locations (1)

- University of Central Lancashire Cyprus, Larnaca, Pyla, Cyprus

## Recent Field Changes (last 30 days)

- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of central lancashire cyprus|larnaca|pyla|cyprus` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06884566.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06884566*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*